33 PDF
33 PDF
33 PDF
4 (2009), 972-980
ISSN: 0974-1496
CODEN: RJCABP
http://www.rasayanjournal.com
ABSTRACT
The discovery, development and identification of biologically active compounds has gain lot of importance in the
recent years, even though there is considerable number of adverse effects, the medicinal chemists have always tried
to design drug substance possessing maximum therapeutic application and minimum toxicity. Combinatorial
synthesis has brought lot of evolution in the recent trends of drug synthesis. Naphthalene has been identified as new
range of potent antimicrobials effective against wide range of human pathogens. They occupy a central place among
medicinally important compounds due to their diverse and interesting antibiotic properties with minimum toxicity.
Keywords: Naphthalene, antimicrobial activity.
INTRODUCTION
Naphthalene as antimicrobial agent
Several naphthalene containing drugs are available, such as nafacillin, naftifine, tolnaftate, terbinafine,
etc. which play vital role in the control of microbial infection. Several other synthetic derivatives have
also been reported which possess significant and satisfactory antimicrobial property. -naphthol
commonly used as dye possess a very good antimicrobial property 1
Chemistry of naphthalene:
1. Naphthalenes
Naphthalene is the simplest and the most important member of this class of arenas, in which two benzene
rings are fused in ortho positions.
Fig-1:Naphthalene
Physicochemical properties
Naphthalene is a colorless solid which forms shining flaked-crystal, its melting point is 82.2oC. It has
familiar odor of moth balls. It is very volatile and sublimes slowly at room temperature. Naphthalene is
insoluble in water, moderately soluble in alcohol, highly soluble in ether and benzene. It burns with a
smoky flame.
Naphthalene gives the usual aromatic electrophonic substitution reaction as shown in Fig 2.
H E
+
E
Preparation
Both 1 and 2 naphthols are prepared from the corresponding naphthalene sulphonic acids by fusion with
sodium hydroxide at 300oC followed by acidification.
ONa
SO3H OH
H2SO4 NaoH
0 0
40 c 300 c H2O
Physicochemical properties
They are colorless solid compounds having a melting point of 123-124oC, they are insoluble in water,
benzene and highly soluble in alcohol and ether. Naphthol gives all the chemical reactions characteristic
of phenols 2.
Review of research on naphthalene
Mkpenie et al., 3 have tested azo-2 naphthol and 2-napthol against five representative human pathogenic
microorganisms i.e. Staphylococcus aureus, Escherichia coli, bacillus subtilis, pseudomonas aeruginosa
and streptococcus faecalis. Both azo-2 naphthol and 2-napthol were found equally effective against all
the organisms tested.
N
N
OH
R
S
N N
Fig.-6: Benzylidene aminonaphtho thiazole
1
R
Fig.-7: 2-hydroxy-1-napthalene with 6,7-dihydro-13H dibenzo [e,n][1,4]doxomin-2,11 diamine
The compound 2-hydroxy-1-napthalene with 6,7-dihydro-13H dibenzo [e,n] [1,4] doxomin-2,11 diamine
were studied on the Gram-negative bacteria like Escherichia coli (ATCC 25922) and Pseudomonas
aeruginosa (ATCC 27853), the Gram-positive bacteria like S. aureus (ATCC 25923), MRSA (clinical
isolate), Enterococcus faecalis (ATCC 29212) and fungi like Candida krusei (ATTC 6258) and Candida
albicans (ATCC 10231). The compound was found to have potent antibacterial and antifungal activity.
Nagaraja et al., 8 synthesis of naphthofurans derivative coupled with both quinoline and azetidine nucleus.
This compound exhibited significant antimicrobial activities 8.
1
R R
2
N R
3
R
NH
O N
O Cl
O
Fig.- 8: N-[3-Chloro-2-(2-chloroquinolin-3-yl)-4-oxoazetidin-1-yl] naphtho [2, 1-b] furan-2-Carboxamide
H
N
O
O
Fig.-9: 2-Aryl-2,3-dihydronaphtho[2,1-b]furo[3,2-b]pyridin-4(1H)-ones
R=H,Cl,Br,CH3,OCH3,NO2
Sharma et al., 10 prepared some naphthalene derivatives by incorporating azetidinyl and thiazolidinyl
moieties at its a- or b-positions such as a-(3-chloro-2-oxo-4-substituted)aryl-1-azetidinyl) naphthalenes 6
10, a-((substituted)aryl-4-oxo-1,3-thiazolidin-3-yl) naphthalenes1115, b-(3-chloro-2-oxo-4-substituted
aryl-1-azetidinyl) naphthalenes 2125, and b-(substitutedaryl-4-oxo-1,3-thiazolidin-3-yl) naphthalenes
2630. These compounds have also been screened for acute toxicity and anti-inflammatory and analgesic
activities. Compounds which showed better anti-inflammatory and analgesic activities were also
examined for their ulcerogenic liability and underwent a cyclooxygenase assay 10.
Cl
S
O R R O
O R
N N S Cl
N N
O R
N
HN
N Cl
HN
Cl
Fig.-11: 2-(5,5,8,8-tetramethyl-5,6,7,8 tetrahydronaphthalen-2-yl)-1H-benzimidazole-5-carboxamidine
OR OR
MeO MeO
OMe Br
Fig.-12:(5,6 dimethoxynapthalene-2-carboxylic acid) (5-bromo-6methoxynapthalene-2-carboxylic acid)
2
1 O R
O R
1 3
2 R R
NH R
3
R NH
. OH O OCH3 O
1
O R
2
NH R
3
Cl R
OH O
Huang et al., 14, evaluated the antimicrobial potential of 18 synthetic naphthalene derivatives and tested
for their anti-inflammatory activity. They prepared naphthalene derivative prepared according to the
Mannich reaction 12.
Ahemed et al., 15 substituted several new 1 H-benzo chromene derivatives with 2-napthols and found
them to possess enhanced biological activity against bacterial, fungal and viral pathogens of human 15.
Azarifar et al., 16 the syntheses of twenty-four 3, dinaphthalene -1-yl substituted 2-pyrazolines containing
certain groups as substituents both on the naphthalene and pyrazoline rings. The compounds were tested
in vitro for antimicrobial activity against Escherichia coli, Staphylococcus aureus, Klebsiella
pneumoniae, Proteus mirabillis, Shigella dysentry and Salmonella typhii at a temperature of 37 C
(1C). It was observed that 81% of the total samples tested showed antimicrobial activity against all the
organisms tested 16.
4
R
N N H
2 H 3
R R
1 H
R
Fig.-15: 3, dinaphthalene -1-yl substituted 2-pyrazolines
H
N N
OCH2
O S
OCH2 NH2
O
OCH2
O O
Fig.-19: 1-(2-naphthyloxyaceyl)-5-substituted-3-thiosemicarbazide
N N
O NHR
O
Fig.-20: 2-(2-naphthyloxymethyl)-5-substitutedamido-1,3,4-oxadiazole
H
N N
O S
N
R
Fig.-21: 2-(2-naphthyloxymethyl)-5-substitutedamido-1,3,4-thidiazole
N N
O NHR
S
Fig.-22: 5-(2-naphthyloxymethyl)-5-substitutedamido-1,2,4-triazole-3-thiones
R=CH3, C2H5, CH2-CH=CH2, C6H5
NH R
Fig.-23: 1-acetyl-5-substitutedaryl-3-(-aminonaphthyl)-2-pyrazolines
NH
CO NHR
Strom et al., 20 have reviewed the important structural features affecting the antimicrobial activity of 15-
residue derivatives of lactoferricins. His investigations were based on an alanine-scan of a 15 residue
bovine lactoferricin derivative that revealed the absolute necessity of two tryptophan residues for
antimicrobial activity. They prepared a synthetic 15-residue derivative of bovine lactoferricin (LFB).
containing naphthalene derivative and concluded that 2-naphthalene peptide more active than 1-
naphthalene isomers; 2, the naphthalene moiety in 2-Nal is pointing more away from the b-carbon atom
than in 1-Nal, giving 2-Nal a more elongated shape; 2-Nal thereby has a longer side chain than 1-Nal, and
was able to penetrate deeper into the cell membrane of bacteria, thus offering an explanation as to why
the 2-Nal peptides display a higher antimicrobial activity than the 1-Nal peptides 18.
Oliveira et. al. 21 synthesizd 3-Hydrazino-naphthoquinones as analogs of lapachol. Several 1, 4-
naphthoquinone derivatives having a hydrazino side chain were synthesized from 3-diazo-naphthalene-
1,2,4-trione and tested as potential antimicrobial agents. These naphthoquinone derivatives 2-[N-(1-
acetyl-2-oxo-propylidene) -hydrazino] -3-hydroxy [1,4] naphthoquinone, ethyl2-[(3-hydroxy-1,4-dioxo-
1,4-dihydro-naphthalen-2-yl)-hydrazono]-3-oxo-butyrate, t-butyl2-[(3-hydroxy -1,4-dioxo-1,4-dihydro-
naphthalen-2-yl)-hydrazono]-3-oxobutyrate, 3-hydroxy-2-[(di -O-isopropylidene-malonate)-hydrazino]-1,
4 naphtho-quinone, and diethyl 2- [(3-hydroxy -1,4- dioxo-1,4- dihydro naphthalene -2-yl)-hydrazono]-
malonate showed greater antibacterial activity at the level of the preliminary susceptibility testing in disk
21
.
O
OH
O
N 2
NH R
O 1
O R
Fig.-25: Naphthoquinone derivatives
Ambrogi et al., 22 prepared new halogenated 1, 4-naphthoquinones together with other known 1, 4-
naphthoquinones and screened these derivatives for their antibacterial activity by turbidimetric method
and for antifungal activity by diffusion method on agar medium.
O
4 1
R R
3 2
R R
O
Fig.-26: 1, 4-naphthoquinones
Fig.-28:2-arylamino-5-(2-napthyloxymethyl)-1, 3, 4-oxadiazoles
NH
S
OC 2 H 5
Fig.-29:Naficilin
REFERENCES
1. Wilson and Gisvolds, Textbook of organic medicinal and pharmaceutical chemistry,. Lippincott,
Williams and Wilkins, Philadelphia pp, 255-257 (2004).
2. A. Behal, B. Bahal, A textbook of organic chemistry, S Chadn and Company Ltd., New Delhi, pp
834-835, (2005).
3. V. Mkpenie, G. Ebong, I. B. Obot, B. Abasiekong, E. Journal of chemistry, 5,431-434(2008).
4. A. Faizul, S. Singh, S. Khokhra, P. Om, J Zhejiang Univ , 8, 446-452(2007).
5. Mustafa Yildiz, Askin Kirnz, and Basaran Dulger , J.Serb.Chem.Soc.72 (3), 215-224 (2007).
6. Zeynep Ates, Alag, Mehmet Alpl, Canank Kusal, Arch. Pharm. Chem. Life Sci., 339,74-80
(2006).
7. Z. Alagoa, S.Yildiz, E. Buyukbingo, Chemotherapy, 53,110113(2007).
8. K Nagaraja, G.Prakash, M. Kumaraswamy, V. Vaidya, and K. Mahadevanb, Arkivoc, (xv), 160-
168 (2006).
9. K Nagaraja, G.Prakash, M. Kumaraswamy, V. Vaidya, and K. Mahadevanb, Arkivoc,(xv) ,142-
152 (2006).
10. S. Sharma, T. Singh, R. Mittal, K Saxena, V. Srivastava, A. Kumar, Arch. Pharm. Chem. Life
Sci., 339, 145-152 (2006).
11. Z. Ates-Alag, M. Alp, C. Kus, S. Yildiz, E. Buyukbing,H. Gker, Arch. Pharm. Chem. Life Sci.
339, 7480 (2006).
12. S. Goksu, M. Tansu, H. Ozdemir, H. Secen, Turk j Chem. 29,199-205 (2005).
13. C. Kyu Ryu and M. Chase, Arch Pharm Res, 28, 750-755 ( 2005).
14. M. Huang, S. Nan Wu, J. Wang, C. Lin, S. Lu, L. Liao, and A. Shen, Drug Devpt Res., 60, 261
269 (2003).
15. Ahmed H. Bedair, Hussien A- Emam, Nagwa A. Ei-hady,Farmaco, 56, 965-973 (2001).
16. Davood Aazarifar and Maseud Shebanzadeh, Molecules, 7, (2002) 885-895.
17. S. Gulay, E. Palaska, M. Ekizoglu, M Ozap, Farmaco, 57, 539-542 (2002).
18. E. Palaska, G. Sahin, P. Kelicen, N. Tugba, Farmaco, 57, 101107(2002).
19. E. Bansal, V. Srivastava, A. Kumar, Eur. J. Med. Chem., 36, 8192 (2001).
20. B. Strom, B. Haug, O. Rekdal, L. Skar, W. Stensen, and S. Svendsen, Biochem. Cell Biol, 80, 65
74 (2002).
21. C. Oliveiraa, F. Mirandaa, F. Ferreiraa, C. Freitasb, F. Rabellob, M. Carballidod and C. Correab,
J. Braz. Chem. Soc., 12,339-345 (2001).
22. V. Ambrogi, D. Artini, I. Decarneri, S. Castellino, E. Dradi,W. Logemann, G. Meinardi, M.
Disomma, G. Tosolini, Br. J. Pharmac., 40, 871-880 (1970).
23. M.Husain, A. Kumar and R. Srivastava, Currt Sci, 55, 644-646 (1986).
http:// www.rasayanjournal.com
Life Membership for Individuals: Rs.8000/- for Indians and USD 1000 for others.
Life Membership for Institutional: Rs.10000/- for Indians and USD 1500 for others.
BENEFITS OF LIFEMEMBERSHIP:
1. You will receive the journal and all its special issues regularly life long.
2. You will receive all other future publications (Proceedings, Edited Books, Monographs
etc.) published by RJC on 50% discount.
3. If you are a LIFE MEMBER, you need not to pay subscription fee every time for
publication of your paper in RJC.
4. Youll be a Reviewer for RJC manuscripts of your Field Interest and well publish your
name in our journal.
5. You will be exempted from Registration Fee of any National or International future
events (i.e. workshop, seminars, Conferences etc.) organized by RJC.
6. You may be elected as Editorial Member of RJC (Note: Itll depend upon your
publication and scientific achievements).
7. Youll have a very personalized gift from RJC with Complements.
For being a Life Membership, just mail to editor-in-Chief with your detailed Resume.